Exploring international collaborations to accelerate Alzheimer’s research
Senior man taking pills, closeup

Exploring international collaborations to accelerate Alzheimer’s research

**Exploring International Collaborations to Accelerate Alzheimer’s Research**

Alzheimer’s disease is a complex and growing health issue worldwide. To combat this, researchers and organizations are coming together in international collaborations to accelerate the search for treatments and a cure. Here’s a look at some of the key efforts:

### The Alzheimer’s Association: A Global Leader

The Alzheimer’s Association is a leading nonprofit organization dedicated to Alzheimer’s and dementia research. In 2024, they committed a record $109 million to research, including $76 million in grants for new scientific investigations. This funding supports over 1,110 active projects in 56 countries, spanning six continents[1].

One notable initiative is the Part the Cloud program, which has funded 71 studies since its inception in 2012. These studies have generated over $1.4 billion in follow-on funding. The U.S. POINTER study, which explores lifestyle interventions and dementia risk, has enrolled over 2,000 participants from diverse backgrounds[1].

### Global Alzheimer’s Platform Foundation

The Global Alzheimer’s Platform Foundation (GAP) is another organization speeding up the delivery of Alzheimer’s treatments. They have partnered with the Biomarkers of Aging Consortium to investigate potential biomarkers for Alzheimer’s disease. This collaboration will utilize Bio-Hermes-001 data to transform diagnosis, prognosis, and treatment[2].

### Texas Alzheimer’s Research and Care Consortium

In Texas, the Texas Alzheimer’s Research and Care Consortium (TARCC) brings together several institutions to advance Alzheimer’s research. Their annual symposium features keynote speakers like Stephen Waring, who discusses leveraging precision medicine, AI, and digital health to prevent Alzheimer’s disease. TARCC also supports various studies, including those on immune cell regulation and cognitive impairment[3].

### Davos Alzheimer’s Collaborative

The Davos Alzheimer’s Collaborative is a global initiative aiming to cure Alzheimer’s disease and improve brain health. They recently convened global leaders to address the escalating challenge of Alzheimer’s and dementia. The collaborative has outlined five bold actions to launch the next phase of G7 commitment, emphasizing the need for sustained global response[4].

### Alzheimer’s Association and Sigma Gamma Rho Sorority Partnership

The Alzheimer’s Association has also partnered with Sigma Gamma Rho Sorority to promote brain health and support families affected by Alzheimer’s disease. This two-year partnership will focus on awareness and education, highlighting the importance of community involvement in the fight against Alzheimer’s[5].

### Conclusion

International collaborations are crucial in accelerating Alzheimer’s research. Organizations like the Alzheimer’s Association, Global Alzheimer’s Platform Foundation, Texas Alzheimer’s Research and Care Consortium, and the Davos Alzheimer’s Collaborative are working together to advance our understanding of the disease and find effective treatments. By pooling resources and expertise, these collaborations aim to make significant strides in combating Alzheimer’s disease and improving brain health worldwide.